We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+25.53%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$2.84B
AUM Growth
+$360M
Cap. Flow
-$149M
Cap. Flow %
-5.26%
Top 10 Hldgs %
25.12%
Holding
310
New
37
Increased
50
Reduced
189
Closed
10

Top Buys

Rank Stock Value
1
MEDP icon
Medpace
MEDP
+$24.7M
2
ARNA
Arena Pharmaceuticals Inc
ARNA
+$21.7M
3
FOLD
Amicus Therapeutics
FOLD
+$12.1M
4
PBH icon
Prestige Consumer Healthcare
PBH
+$11.6M
5
LGND icon
Ligand Pharmaceuticals
LGND
+$10.8M

Top Sells

Rank Stock Value
1
IMMU
Immunomedics Inc
IMMU
+$51M
2
ETSY icon
Etsy
ETSY
+$38.3M
3
AIMT
Aimmune Therapeutics
AIMT
+$33.6M
4
BSTC
BioSpecifics Technologies Corp.
BSTC
+$19.5M
5
TTD icon
Trade Desk
TTD
+$12.2M

Sector Composition

Rank Sector Weight
1 Healthcare 26.47%
2 Technology 23.43%
3 Industrials 17.34%
4 Consumer Discretionary 13.01%
5 Communication Services 6.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZBH icon
151
Zimmer Biomet
ZBH
$18.5B
$2.71M 0.1%
18,101
-4,836
-21% -$683K
KRNT icon
152
Kornit Digital
KRNT
$774M
$2.7M 0.1%
30,334
-1,177
-4% -$90.4K
ERII icon
153
Energy Recovery
ERII
$411M
$2.69M 0.09%
197,199
-7,946
-4% -$84.8K
CRNC icon
154
Cerence
CRNC
$397M
$2.65M 0.09%
26,393
-12,807
-33% -$955K
BRKR icon
155
Bruker
BRKR
$8.56B
$2.53M 0.09%
46,681
-3,315
-7% -$159K
XPEL icon
156
XPEL
XPEL
$1.33B
$2.48M 0.09%
48,189
-42,357
-47% -$1.53M
CLAR icon
157
Clarus
CLAR
$146M
$2.44M 0.09%
158,337
-6,221
-4% -$94.6K
SHYF
158
DELISTED
The Shyft Group
SHYF
$2.42M 0.09%
85,158
-3,578
-4% -$85.7K
EXPO icon
159
Exponent
EXPO
$3.25B
$2.41M 0.08%
26,749
-1,064
-4% -$84.8K
CSTL icon
160
Castle Biosciences
CSTL
$1.01B
$2.4M 0.08%
35,808
+2,367
+7% +$128K
ATRS
161
DELISTED
Antares Pharma, Inc.
ATRS
$2.39M 0.08%
+599,628
New +$1.94M
HLIT icon
162
Harmonic Inc
HLIT
$1.28B
$2.34M 0.08%
316,840
+42,021
+15% +$276K
BANR icon
163
Banner Corp
BANR
$2.41B
$2.34M 0.08%
50,222
-18,012
-26% -$743K
AIRG icon
164
Airgain
AIRG
$72.4M
$2.31M 0.08%
130,174
-5,892
-4% -$82K
BWXT icon
165
BWX Technologies
BWXT
$15.5B
$2.3M 0.08%
38,210
-404
-1% -$23.3K
DLB icon
166
Dolby
DLB
$5.83B
$2.3M 0.08%
23,686
-12,338
-34% -$1.02M
FLIR
167
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
$2.27M 0.08%
51,668
-7,951
-13% -$307K
MLAB icon
168
Mesa Laboratories
MLAB
$570M
$2.25M 0.08%
7,838
-368
-4% -$101K
CSCO icon
169
Cisco
CSCO
$490B
$2.23M 0.08%
49,847
-690
-1% -$28.4K
CBZ icon
170
CBIZ
CBZ
$2.96B
$2.23M 0.08%
83,607
-3,008
-3% -$74K
CIEN icon
171
Ciena
CIEN
$56.3B
$2.22M 0.08%
42,022
-7,601
-15% -$338K
DEN
172
DELISTED
Denbury Inc.
DEN
$2.22M 0.08%
+86,392
New +$1.75M
IEX icon
173
IDEX
IEX
$17.2B
$2.22M 0.08%
11,133
-1,788
-14% -$340K
PRFT
174
DELISTED
Perficient Inc
PRFT
$2.21M 0.08%
46,328
-1,951
-4% -$88.5K
QADA
175
DELISTED
QAD Inc.
QADA
$2.2M 0.08%
34,813
-1,634
-4% -$83.9K
5 6
7
8 9

Similar funds

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return

Rice Hall James & Associates's Q4 2020 Portfolio in Review

As of Q4 2020, Rice Hall James & Associates held 310 positions worth $2.84B, up 15% from $2.48B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Rice Hall James & Associates withdrew a net $149M in Q4 2020, closing 10 positions and reducing 189 holdings. Its most notable exit was Immunomedics Inc, an estimated $51M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in Medpace worth $27.3M.

  • Rice Hall James & Associates's largest Q4 2020 buy was Medpace: 195,984 shares worth $27.3M.
  • Rice Hall James & Associates added most to Prestige Consumer Healthcare in Q4 2020, an estimated $11.6M increase.
  • Rice Hall James & Associates's biggest Q4 2020 reduction was Etsy, cutting an estimated $38.3M.
  • Rice Hall James & Associates fully exited Immunomedics Inc in Q4 2020, selling an estimated $51M.
  • Rice Hall James & Associates's ten largest holdings make up 25% of its $2.84B portfolio in Q4 2020.
  • Rice Hall James & Associates opened 37 new positions and closed 10 in Q4 2020.
  • Rice Hall James & Associates's portfolio value rose 15% quarter-over-quarter to $2.84B.

Based on Rice Hall James & Associates's 13F filing for Q4 2020, filed 16 Feb 2021.